2026 NEAETC CT LP HIV Symposium:
Empowering Progress: Redefining HIV Prevention and Treatment for Tomorrow
Join us on Tuesday, June 23, 2026, for a dynamic, in-person symposium bringing together healthcare providers, public health professionals, and community partners dedicated to advancing HIV prevention and care across Connecticut. This full-day event will convene for a full day of learning, collaboration, and networking.
The symposium will explore the evolving landscape of HIV prevention and treatment, beginning with an overview of current strategies and emerging innovations, including PrEP and long-acting injectable options. A diverse panel of community-based providers and clinical leaders will share real-world insights on implementing prevention models, addressing barriers, and expanding access to care.
Attendees will also hear from a keynote speaker on the history and future of the Ryan White Program, followed by expert-led sessions on advancements in HIV treatment, long-term care, and managing comorbidities associated with aging with HIV.
An interactive patient panel will offer powerful, real-life perspectives on living long-term with HIV, highlighting challenges, successes, and opportunities for improved patient-centered care. Throughout the day, participants will engage in meaningful discussions, gain practical knowledge, and identify actionable strategies to strengthen HIV prevention and treatment efforts.
This symposium offers a valuable opportunity to connect with peers, learn from experts, and contribute to shaping the future of HIV care in Connecticut and beyond.
Accreditation Statement: Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement: Yale School of Medicine designates this Live Activity for a maximum of 4.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure Policy: It is the policy of Yale School of Medicine, Continuing Medical Education (CME), to ensure balance, independence, objectivity, and scientific rigor in all its educational programs. All individuals involved in the development and presentation of Accredited Continuing Education activities are required to disclose all financial relationship(s) with ineligible companies (those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients) that has occurred within the past 24 months; and the opportunity to affect the content of CME about the products or services of the commercial interests. This information is disclosed to all activity participants prior to the commencement of the educational activity.
Mitigation of Financial Relationships Statement: Yale CME adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible companies. All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
